Wu Xi-Yan, Lu Jin-Chun, Peng Xin-Hua, He Jing-Liang, Wang Dao, Dai Cong-Ling, Zhu Wen-Bing, Liu Gang, Li Wei-Na
Center for Reproductive Medicine, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China.
Center for Reproductive Medicine, Southeast University Affiliated Zhongda Hospital, Nanjing 210009, China.
Asian J Androl. 2025 Sep 1;27(5):621-626. doi: 10.4103/aja2024118. Epub 2025 Mar 11.
This study explores whether the current external quality assessment (EQA) level and acceptable bias for basic semen analysis in China are clinically useful. We collected data of semen EQA from Andrology laboratories in the Hunan Province (China) in 2022 and searched for data in the published literature from January 2000 to December 2023 in China. On the basis of these data, we analyzed the coefficients of variation and acceptable biases of different quality control materials for basic semen analysis through robust statistics. We compared these findings with quality specifications based on biological variation from optimal, desirable, and minimum levels of bias to seek a unified and more suitable semen EQA bias evaluation standard for China's national conditions. Different sources of semen quality control material exhibited considerable variation in acceptable biases among laboratories, ranging from 8.2% to 56.9%. A total of 50.0% of the laboratories met the minimum quality specifications for progressive motility (PR), whereas 100.0% and 75.0% of laboratories met only the minimum quality specifications for sperm concentration and total motility (nonprogressive [NP] + PR), respectively. The Z value for sperm concentration and PR+NP was equivalent to the desirable performance specification, whereas the Z value for PR was equivalent only to the minimum performance specification. This study highlights the feasibility of operating external quality assessment schemes for basic semen analysis using quality specifications based on biological variation. These specifications should be unified among external quality control (EQC) centers based on biological variation.
本研究探讨中国目前基础精液分析的外部质量评估(EQA)水平及可接受偏差是否具有临床实用性。我们收集了2022年中国湖南省男科实验室的精液EQA数据,并检索了2000年1月至2023年12月中国已发表文献中的数据。基于这些数据,我们通过稳健统计分析了基础精液分析不同质量控制材料的变异系数和可接受偏差。我们将这些结果与基于最佳、理想和最小偏差水平的生物学变异的质量规范进行比较,以寻求符合中国国情的统一且更合适的精液EQA偏差评估标准。不同来源的精液质量控制材料在各实验室间的可接受偏差存在显著差异,范围从8.2%至56.9%。共有50.0%的实验室达到了前向运动精子活力(PR)的最低质量规范,而分别有100.0%和75.0%的实验室仅达到精子浓度和总活力(非前向运动[NP]+PR)的最低质量规范。精子浓度和PR+NP的Z值相当于理想性能规范,而PR的Z值仅相当于最低性能规范。本研究强调了使用基于生物学变异的质量规范开展基础精液分析外部质量评估计划的可行性。这些规范应在基于生物学变异的外部质量控制(EQC)中心之间实现统一。